For 10 years, Groupe Grimaud has been committed to the field of health. Vivalis, Groupe Grimaud's first biotechnical investment, now listed on Euronext (VLS) uses its ultra-modern GMP facilities to develop unique solutions to fight against viral illnesses, based on its EB66® cell line from duck embryo stem cells. Today, the world's largest pharmaceutical manufacturers have acquired licenses to develop vaccines based on the EB66® line. This same platform also allows the production of pharmaceutical proteins of a quality that is currently unequalled. Lastly, the company is developing its own molecules to fight against hepatitis C. Filavie, the other biotechnical subsidiary of Groupe Grimaud offers its range of autogenous vaccines against bacterial pathogens to the animal-production sector. It is also developing an innovative concept of natural microbial flora, of defined and stable composition, based on Lactobacillus and Bacillus distributed in drinking water, which improves both the technical performance and the environmental conditions of animal livestock. Lastly, Hypharm produces rabbit serum for polyclonal antibodies production used in human therapeutic applications involving organ transplants. Today, with their 9 centres of animal genetic selection in France, USA an China, as well as subsidiaries - in the UK, France, Italy, Poland, Hungary, China, Vietnam, the USA and Brazil – the companies: Grimaud Frères Sélection, Hypharm, Hubbard, Novogen and Newsham Choice Genetics offer the widest range of breeding stock to the poultry, rabbit and pig industries throughout the world, meeting both their quality and productivity targets. Resulting from conventional genetic selection programmes, supported by genomic technology, our breeding stock has the best genetic potential to fit the specific requirements of each market. The production of ducklings, Groupe Grimaud’s initial business, is performed by Grimaud Frères Sélection and its subsidiaries. They produce nearly one million commercial ducklings per week, mainly for the French and European markets. Leader in Europe, Grimaud Frères Sélection offers the largest product range of ducklings--Muscovy, Pekin and Mule ducks--to meet each type of market segment: live, whole carcass, cut-up and further processed. Having its production facilities organised in independent compartments around its regional hatcheries, using its own logistical tools and being certified ISO 9001, Grimaud Frères Sélection provides a secure supply to the duck industry.